Pfizer 20 abr 2026 A controversy over research monkeys highlights ambiguity over health standards - statnews.com
Amgen 20 abr 2026 Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
Pfizer 20 abr 2026 Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source - South China Morning Post
Pfizer 18 abr 2026 Lobbying Update: $4,420,000 of PFIZER INC. lobbying was just disclosed - Quiver Quantitative
FierceBiotech 16 abr 2026 Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech 6 abr 2026 With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine
BioNTech 2 abr 2026 Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - Reuters
FierceBiotech 1 abr 2026 Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech 1 abr 2026 Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down
BioPharma Dive 23 mar 2026 Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
FierceBiotech 23 mar 2026 Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push